Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Katz alleges Army Radio workers misled High Court in bid to halt closure28.12.2025 - 210 Famous Frozen yogurt Flavors All over The Planet05.06.2024
- 3Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts21.11.2025
- 4Giude to Best Web based Learning Stage01.01.1
- 5Picking Your Next SUV: 4 Brands Offering Execution, Solace, and Wellbeing05.06.2024
- BHP liable for 2015 Brazil mine disaster: UK court
- I decided to become a single mother by choice. I wasn't ready to stop dating.
- Saturn's moon Titan may not have a buried ocean as long suspected, new study suggests
- Tens of thousands protest as far-right AfD forms new youth group
- Vote In favor of Your Favored Occasion Arranging Administration
- 5 Wellbeing Applications Assist You With remaining Fit
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- From Representative to Business visionary: Private issue Victories
- Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
